ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,089, issued on Oct. 7, was assigned to TYK MEDICINES INC. (Zhejiang, China).
"3-oxadiazolyl substituted pyrazolo[1,5,apyrimidines for ROS1, NTRK, and ALK mediated diseases" was invented by Jun Li (Zhejiang, China), Chengshan Niu (Zhejiang, China), Apeng Liang (Zhejiang, China) and Yusheng Wu (Zhejiang, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is the compound represented by formula I, or tautomer thereof, or meso thereof, racemate thereof, and mixture of meso and racemate thereof, or enantiomer thereof, diastereomer, and mixture of enantiomer and diastereomer, or pharmaceutically acceptable salt thereof, or deuterate thereof. The ...